Qualitative and Quantitative Magnetic Resonance Imaging Phenotypes May Predict CDKN2A/B Homozygous Deletion Status in Isocitrate Dehydrogenase-Mutant Astrocytomas: A Multicenter Study-Reference-Cited by-同舟云学术

Qualitative and Quantitative Magnetic Resonance Imaging Phenotypes May Predict CDKN2A/B Homozygous Deletion Status in Isocitrate Dehydrogenase-Mutant Astrocytomas: A Multicenter Study

Published:2023 Issue:2 Volume:24 Page:133
ISSN:1229-6929
Container-title:Korean Journal of Radiology
language:en
Short-container-title:Korean J Radiol

Author:

Park Yae Won¹^ORCID,Park Ki Sung²^ORCID,Park Ji Eun³^ORCID,Ahn Sung Soo¹^ORCID,Park Inho⁴⁵^ORCID,Kim Ho Sung³^ORCID,Chang Jong Hee⁶^ORCID,Lee Seung-Koo¹^ORCID,Kim Se Hoon⁷^ORCID

Affiliation:

1. Department of Radiology and Research Institute of Radiological Science and Center for Clinical Imaging Data Science, Yonsei University College of Medicine, Seoul, Korea.

2. Department of Mechanical Engineering, Pohang University of Science and Technology, Pohang, Korea.

3. Department of Radiology, Ulsan University College of Medicine, Seoul, Korea.

4. Center for Precision Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

5. Department of Pathology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

6. Department of Neurosurgery, Yonsei University College of Medicine, Seoul, Korea.

7. Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.

Funder

National Research Foundation of Korea

Yonsei University College of Medicine

Publisher

The Korean Society of Radiology

Subject

Radiology, Nuclear Medicine and imaging

Link

https://kjronline.org/pdf/10.3348/kjr.2022.0732

Reference45 articles.

1. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

2. cIMPACT‐NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT‐Utrecht meeting on future CNS tumor classification and grading

3. Targeted copy number analysis outperforms histologic grading in predicting patient survival for WHO grades II/III IDH-mutant astrocytomas

4. Prognostic relevance of genetic alterations in diffuse lower-grade gliomas

5. IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III diffuse gliomas

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Grading diffuse glioma based on 2021 WHO grade using self-attention-base deep learning architecture: variable Vision Transformer (vViT);Biomedical Signal Processing and Control;2024-05

2. Artificial Intelligence Imaging for Predicting High-risk Molecular Markers of Gliomas;Clinical Neuroradiology;2024-01-26

3. Radiogenomics of adult intracranial gliomas after the 2021 World Health Organisation classification: a review of changes, challenges and opportunities;Quantitative Imaging in Medicine and Surgery;2023-11

4. Correlating MRI features with additional genetic markers and patient survival in histological grade 2-3 IDH-mutant astrocytomas;Neuroradiology;2023-06-15

5. Editorial for “Preoperative Prediction of CDKN2A/B Homozygous Deletion Status in Astrocytoma: A Deep Learning‐Based Radiomics Model Using Magnetic Resonance Images;Journal of Magnetic Resonance Imaging;2023-06-12